The development of cytomegalovirus (CMV) infection in the placenta was studied in Hartley guinea pigs inoculated at midgestation, and its role in determining the outcome of fetal CMV infection was assessed. A hematogenous spread of CMV from the mother to the placenta occurred early during the course of the infection. However, the virus remained present in placental tissues long after CMV had been cleared from maternal blood (i.e., 3 and 4 weeks postinoculation). At that time, the virus was able to replicate in placental tissues in the presence of specific maternal antibodies. Viral nucleocapsids were seen within nuclei of trophoblastic cells, and virions were present surrounding infected cells. In addition, typical CMV-induced histopathological lesions bearing CMV antigens were consistently localized at the transitional zone between the capillarized labyrinth and the noncapillarized interlobium. Whenever CMV infection of the fetus occurred, virus was isolated from the associated placenta. Among placental-fetal units with CMV-infected placentas, only 27% of the fetuses were found to be infected. In addition, there was a delay in the establishment of the infection in the fetus in relation to the placenta, although frequencies of virus isolation in placental and fetal tissues peaked at 3 weeks after CMV inoculation. These results suggest that during primary CMV infection of pregnant guinea pigs, the placenta not only serves as a reservoir for CMV but also acts to limit transmission of the virus to the fetus.
The development of cytomegalovirus (CMV) infection in the placenta was studied in Hartley guinea pigs inoculated at midgestation, and its role in determining the outcome of fetal CMV infection was assessed. A hematogenous spread of CMV from the mother to the placenta occurred early during the course of the infection. However, the virus remained present in placental tissues long after CMV had been cleared from maternal blood (i.e., 3 and 4 weeks postinoculation). At that time, the virus was able to replicate in placental tissues in the presence of specific maternal antibodies. Viral nucleocapsids were seen within nuclei of trophoblastic cells, and virions were present surrounding infected cells. In addition, typical CMV-induced histopathological lesions bearing CMV antigens were consistently localized at the transitional zone between the capillarized labyrinth and the noncapillarized interlobium. Whenever CMV infection of the fetus occurred, virus was isolated from the associated placenta. Among placental-fetal units with CMV-infected placentas, only 27% of the fetuses were found to be infected. In addition, there was a delay in the establishment of the infection in the fetus in relation to the placenta, although frequencies of virus isolation in placental and fetal tissues peaked at 3 weeks after CMV inoculation. These results suggest that during primary CMV infection of pregnant guinea pigs, the placenta not only serves as a reservoir for CMV but also acts to limit transmission of the virus to the fetus.
Cytomegalovirus (CMV) is the most frequent cause of congenital viral infection in humans (15) . These infections are thought to be acquired via transplacental transfer of CMV and range in severity from an asymptomatic process with viruria and low birth weight to severe brain damage, neonatal cytomegalic inclusion disease, or death. Although CMV infections during pregnancy have been the subject of considerable study, little attention has been given to the associated placentas. Reports describing placental damage due to human CMV generally have not referred to specific areas or cells in the placenta, to the time course of appearance of the damage, or to its effect on the outcome of the fetus (1, 2, 4, 6, (22) (23) (24) (25) (26) . Thus, knowledge of the events associated with placental CMV infection is fragmentary, and the mechanisms of transplacental transmission of CMV remain unclear.
Guinea pigs infected with guinea pig CMV have been used as a model for the study of human CMV infection (3) . Transplacental transmission of CMV has been demonstrated to occur in the guinea pig, resulting in the birth of congenitally infected offspring (5, 13, 19, 21) . Thus, this animal model is a unique tool for studying mechanisms of transmissions of virus from mother to infant. Furthermore, the structure of the guinea pig placenta also makes this species a promising subject for studies of in utero transfer of CMV. Placentation in the guinea pig occurs in a manner similar to that of humans, and both guinea pig and human placentas are classified as hemomonochorial (27) . The guinea pig placenta shows very distinctive features at the light-microscope level, notably well-defined lobular organization, and the interface between the fetal and maternal circulation is somewhat similar to that of the mature human placenta (7, 20 guinea pigs, CMV has been isolated from placental tissues (5, 12, 19) . However, no report has systematically evaluated CMV infection at the placental level and its role in the development of fetal CMV infection.
In the present study, we investigated the development of primary acute CMV infection in the mature guinea pig placenta so as to gain insight into the mechanisms of transplacental transfer of CMV. We evaluated the time course of appearance of infectious virus and virus-induced lesions in the placenta in relation to maternal viremia and fetal CMV infection. We assessed the ability of guinea pig placenta to sustain CMV infection, and we determined the type of lesions induced by CMV and their localization in different areas of the placental tissues. Finally, we considered the role played by the CMV-infected placenta in modulating the outcome of CMV infection in the fetus.
MATERIALS AND METHODS
Virus and cell cultures. The prototype strain of guinea pig CMV (no. 22122, American Type Culture Collection, Rockville, Md.) was used. Salivary gland-passaged guinea pig CMV stocks were prepared as described previously (12) . The virus stocks used throughout the study were at passage levels 26 to 28 and had a virus infectivity titer of 7.5 log10 50% tissue culture infective doses per ml.
Both primary and low-passage guinea pig embryo (GPE) cells were used for virus assay. Primary GPE cells were prepared from 30-to 40-day-old embryos of Hartley guinea pigs as described before (16 The amniotic fluid was removed with a 25 gauge needle and a syringe. Each placenta was then detached from its fetal membranes and fetus. The sera obtained from maternal blood samples taken before inoculation and at the time of sacrifice were tested for the presence of neutralizing antibody as described before (12) .
Virus isolation. Virus isolations, titrations, or both were performed on the maternal blood, placental tissues, and fetal tissues. The maternal blood was allowed to clot at room temperature for 30 to 60 min. The serum was decanted, and the clot was briefly minced and used for virus isolation. The placenta was assayed for virus content before and after extensive washing to remove most of the blood. Infectivity titers were determined in the blood-containing and bloodfree placental cell suspensions by serial dilutions of a 10% (vol/vol) suspension. The washed placental cell suspension was obtained as follows: using a 25 gauge needle and syringe, part of each placenta was perfused three times with 10 ml of Hanks balanced salt solution to remove most of the erythrocytes; the placenta was then minced into small pieces, washed three times with 50 ml of Hanks balanced salt solution, and finally homogenized with forceps. Fetal tissues were removed aseptically from each fetus, and the spleen, liver, lung, kidney, salivary gland, and thymus were pooled before virus assay. For each fetus, the brain and amniotic fluid were tested separately.
All samples were inoculated into three to six wells of confluent GPE cell monolayer grown in 24-well plates (Costar) and adsorbed for 1 h at 37°C in a 5% CO2 incubator before culture medium was added. To avoid toxic effects from tissue debris, the culture medium was changed 24 h later. The plates were then incubated at 37°C in a 5% CO2 incubator and examined weekly for 4 weeks for evidence of virus-induced cytopathic effect. For virus titrations, the number of plaques was also determined. All cultures which showed cytopathic effect were harvested and stored at -70°C until needed for final identification. All virus isolates were identified by neutralization tests using type-specific antiserum.
Histology and electron microscopy. For histologic study, a portion of each placenta was fixed in 10% buffered Formalin for 24 h and placed in 20% ethyl alcohol until required for further processing. The fixed placentas were dehydrated through a graded series of ethyl alcohol to xylene, embedded in Paraplast II, sectioned, and stained with routine hematoxylin and eosin stain.
For ultrastructural studies, portions of placentas were minced and fixed overnight in 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2). After fixation, specimens were washed overnight in cacodylate buffer and postfixed in 1.33% osmium tetroxide in S-collidine buffer for 1 h. This was followed by en bloc staining with 0.5% uranyl acetate for 4 (5, 12) . At the time of maternal viremia, isolation of CMV from placentas might simply reflect virus infection of the maternal blood filling the placental blood spaces. These experiments were designed to determine whether CMV could persist in placental tissues after virus had been cleared from maternal blood and to assess the development of CMV infection in the placenta. Groups of pregnant guinea pigs were inoculated with CMV at midgestation and sacrificed on days 8, 14, 21 and 28 post-maternal inoculation. Mothers were evaluated for the presence of virus and neutralizing antibody in their blood. In addition, virus recovery from placental tissues was compared before and after extensive washing of the placental tissues to remove most of the blood contained in the placentas, and virus infectivity titers were determined in the washed placental tissue suspension (Table 1) .
Virus was present in the blood from 6 of 10 mother animals tested on days 8 (Fig.  2) .
Localization of histopathology, antigens, and virus particles in placentas 4 weeks post-maternal CMV inoculation. To differentiate the infection into the various components that make up the placenta, placentas were examined by light microscopy for localization of CMV-specific histopathology and the presence of CMV antigens and by electron microscopy for the presence of viral particles. Placentas were all evaluated at the time when CMV-specific histopathology and intranuclear lesions were most frequently seen, i.e., 4 weeks postinoculation of the mothers with CMV. Areas of CMVspecific necrosis associated with inflammation and inclusions were all found to be strikingly localized at the transitional zone between the capillarized and noncapillarized syncytiotrophoblast. The mature guinea pig placenta is schematically represented in Fig. 3 , showing the localization of CMV-induced histopathology. The hemomonochorial placenta of the guinea pig has a basic lobular arrangement. In these lobules, the maternal blood circulates from the center to the periphery through a complex of lacunae lined by syncytiotrophoblasts. The fetal vessels run centripetally. Different zones can be distinguished within this lobular array: (i) the capillarized labyrinth contains maternal arterial lacunae and fetal vessels which are venous in the center and arterial at the periphery; (ii) the noncapillarized syncytium or interlobium, which may be marginal or interlobar, contains only maternal venous lacunae. CMV-induced lesions *W* =..4, ,~~~~~~~~~~~~~~~~~~~~~~~~. were found to be localized at the transitional zone between these two regions, in the marginal as well as the interlobar transitional zone (Fig. 4) . This zone contains maternal venous lacunae and a reduced number of fetal arterioles.
To determine whether these lesions harbored CMVspecific antigens, immunohistochemical studies were performed using the ABC-immunoperoxidase method. A total of eight placentas were evaluated at 4 weeks postinoculation. In all placentas, the cytoplasm of cells within the lesions was found to stain positively when anti-guinea pig CMV antiserum was used but not when control sera were used (Fig. 5) .
Under electron microscopic examination, intact virusinfected cells were not found easily in placental tissues because of extensive cellular degeneration. Typical intranuclear inclusions were seen within syncytiotrophoblastic cells (Fig. 6) . The intranuclear inclusions consisted of electron-dense and electron-lucent areas. Viral nucleocapsids (100 nm in diameter) were associated primarily with the electron-dense areas. Virions and dense bodies were also Placental CMV infection and outcome of CMV infection in the fetus. To evaluate the role of placental CMV infection on the outcome of CMV infection in the fetus, the frequency of fetal CMV infection was determined in relation to the infection status of the associated placentas. Pregnant animals were evaluated on days 8 to 28 postinoculation. A total of 63 placentas were found to contain CMV; 17 of the 63 fetuses (27%) showed evidence of CMV infection. In contrast, CMV was not isolated from the fetuses from 11 virus-negative placentas.
The development of fetal CMV infection during the course of maternal infection was also determined, to assess whether the placenta played a role in delaying the establishment of the infection in the fetus. The frequency of fetal CMV infection was highest on day 21 post-maternal inoculation, with 9 of 12 (75%) fetuses showing virus. On days 8, 14, and 28 post-maternal inoculation, respectively, 0 of 20, 3 of 17 (18%), and 5 of 14 (36%) of the fetuses tested harbored virus. Uninfected fetuses were obtained at all times after maternal infection. In all instances, each pregnant animal tested had at least one uninfected fetus.
To determine whether, within each fetal-placental unit, there was an association between high concentrations of virus in the placenta and fetal CMV infection, virus infectivity titers were compared in placentas from CMV-infected and uninfected fetuses (Fig. 7) . Placental virus titers were assessed on days 14 (n = 8), 21 (n = 13), and 28 (n = 15) post-maternal inoculation. There was no significant difference between placentas from CMV-infected and uninfected fetuses at each of the time points examined. The mean + standard deviation virus infectivity titers (log1o PFU per milliliter) in placentas from CMV-infected guinea pigs were 1.37 + 1.50, 2.58 + 2.99, and 2. significantly different from those in placentas from uninfected fetuses: 0.76 + 0.38, 2.63 ± 2.66, and 1.99 ± 2.15.
DISCUSSION
The present study has demonstrated that the guinea pig placenta has the ability to support CMV replication during primary acute infection of pregnant outbred guinea pigs. As has been reported before (5, 12) , initial placental infection occurred at the time of maternal viremia, i.e., 1 and 2 weeks '1kb ..C..
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post-maternal inoculation. The virus remained detectable in placental tissue later during the course of maternal CMV infection, at the time when the maternal viremic stage was terminated and when CMV-specific antibodies were present. The findings that highest placental virus infectivity titers and typical intranuclear inclusions containing viral nucleocapsids were observed only at 3 to 4 weeks post-maternal inoculation indicate that replication of CMV occurred in placental tissue with a delayed time course as compared to primary maternal viremia. CMV has been isolated from the human placenta (8, 11, 14) , but replication of human CMV has only been demonstrated after infection in vitro of passaged human placental cells (29) . The placenta has also been reported to be a site of murine CMV replication, although the infection is not readily transmitted to the fetus in this animal model (18) .
Histological evidence of human CMV placental infection has been described by several investigators (1, 2, 4, 6, (22) (23) (24) (25) (26) 28) . Placental changes associated with human CMV infection range from no apparent change to plasmacytic villitis with inclusion bodies. In the present study, histological changes similar to those described in human placentas were observed to appear in guinea pig placentas in a defined chronological order. The finding of severe ischemic injury in several placentas early in the postinoculation period, and in association with abortion, suggests the maternal CMV infection may be accompanied, even before the appearance of classical viral lesions, by placental vascular compromise that may result in fetal death. It is interesting that CMV-induced lesions containing intranuclear inclusions, CMV-specific antigens, and mature virions were only observed late during the course of maternal CMV infection. This suggests that CMV-specific histological findings may depend on the duration of maternal CMV infection, although the stage of gestation at the time of sampling may also have played a role. Indeed, all animals were inoculated at midgestation, and therefore when they were tested at 4 weeks postinoculation, most take place in the latter part of gestation, often leading to an increase in placental transport efficiency (9) .
A striking localization of CMV-specific lesions to the interlobium labyrinthine transitional zone of the guinea pig placentas was apparent. This zone, which is the anatomical junction between the capillarized and noncapillarized trophoblastic tissue, is composed of maternal venous lacunae and fetal arterioles and may be a site of preferential viral localization in this animal model. The only continuous cellular layers separating the maternal and fetal blood circulations in the hemomonochorial placenta of the guinea pig are the syncytiotrophoblast and the endothelium of the fetal capillaries (7) . Typical CMV inclusions and nucleocapsids were observed in trophoblastic cells from placentas examined 4 weeks post-CMV inoculation. Nuclei of other placental cells contained virus nucleocapsids, but due to extensive cell damage, it was not possible to determine whether they were endothelial cells. Johnson (18) reported that during murine CMV infection, inclusions were only observed in trophoblastic cells and never in fetal endothelial cells. The trophoblast, the basic fetal component of the placenta, is known to be responsible for producing enzymes and hormones of vital importance to the maintenance of pregnancy and to fetal growth and development. Its antigenic attributes and its role in transfer of substances between mother and fetus is also known. The degree of impairment of placental function that may result from replication of guinea pig CMV in trophoblastic cells is not known.
The present study has provided some insight into the role of the placenta in determining the outcome of CMV infection in the fetus. On one hand, given the ability of guinea pig placental cells to support proliferation of CMV in vivo, it appears that the placenta may act as a reservoir for the virus from which spread to the fetus can occur. Indeed, fetal CMV infection occurred only in fetuses with placentas with detectable CMV, and did not occur in fetuses with placentas without detectable virus. In addition, it appeared that fetal CMV infection continued to be initiated well after virus in the maternal circulation had been replaced by antibodies, and both rates of fetal and placental CMV infection were found to be highest at 3 weeks post-maternal inoculation. This suggests that fetal infection is dependent upon virus infection in the placenta and that fetuses are not infected by direct seeding from maternal circulation.
On the other hand, our results also support the concept that the guinea pig placenta has the ability to limit transfer of CMV to the fetus. Frequently, CMV infection of the guinea pig placenta occurred without fetal involvement, even though some of the placentas had high virus infectivity titers. A similar situation has been described for humans (14) and for mice (18) . Initial fetal CMV infection was also found to be delayed in relation to initial placental CMV infection. The mechanisms that regulate the containment of CMV in the placenta are not known, although it is possible that acute and chronic inflammatory cells seen at the site of CMV-induced lesions may play a role in containing the infection in placental cells and limiting virus spread to the fetus.
Investigations into CMV infection at the placental level are important to understand the host-virus interactions which determine whether the fetus becomes infected. The present study has demonstrated that the placenta serves as a reservoir for CMV during intrauterine CMV infection and has defined the localization and development of CMV infection in the guinea pig placenta. It appears that during CMV infection, the placenta may play an important role not only in delaying and limiting transmission of the virus from mother to fetus, but also in determining the occurrence of CMV infection in the offspring.
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